COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study.

ABSTRACT:

Background

In the ongoing COVID-19 pandemic, the susceptibility of patients with rheumatic diseases to COVID-19 remains unclear. We aimed to investigate susceptibility to COVID-19 in patients with autoimmune rheumatic diseases during the ongoing COVID-19 pandemic.

Methods

We did a multicentre retrospective study of patients with autoimmune rheumatic diseases in Hubei province, the epicentre of the COVID-19 outbreak in China. Patients with rheumatic diseases were contacted through an automated telephone-based survey to investigate their susceptibility to COVID-19. Data about COVID-19 exposure or diagnosis were collected. Families with a documented history of COVID-19 exposure, as defined by having at least one family member diagnosed with COVID-19, were followed up by medical

SUBMITTER: Zhong J 

PROVIDER: S-EPMC7333992 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature